21/11/2026

Seven Indian children to receive free treatment for rare genetic disorder

Seven children in India diagnosed with Allan-Herndon-Dudley syndrome will receive a year's supply of the medicine tiratricol free of cost on November 30. The treatment, which typically costs between ₹4.68 crore and ₹9 crore annually, has been made affordable through pharmaceutical compounding in the Netherlands, reducing the cost to approximately ₹2.5 lakh per child. This initiative, led by paediatrician Dr. Sivaranjani Santosh and Access to Medicines India, aims to address the financial burden on families. The total cost for one year’s treatment for all seven children is €14,200, with funding sourced from both India and the Netherlands. Dr. Sivaranjani plans to advocate for local compounding of the medicine in India to ensure broader access for affected children.

Published 2 days ago • 19 Nov 2026, 11:38 AM IST

Sources